Gene · 7472
Papers3,221
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,221
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions. | J Pathol | 2021 | 34173975 | PubTator, text mining | PubMed |
| Correction to: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2. | J Exp Clin Cancer Res | 2021 | 34158093 | PubTator, text mining | PubMed |
| A MicroRNA-Based Network Provides Potential Predictive Signatures and Reveals the Crucial Role of PI3K/AKT Signaling for Hepatic Lineage Maturation. | Front Cell Dev Biol | 2021 | 34141708 | PubTator, text mining | PubMed |
| Targeting Signaling Pathway Networks in Several Malignant Tumors: Progresses and Challenges. | Front Pharmacol | 2021 | 34135756 | PubTator, text mining | PubMed |
| NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. | Int J Biol Sci | 2021 | 34131401 | PubTator, text mining | PubMed |
| The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer. | Gastroenterol Res Pract | 2021 | 34122538 | PubTator, text mining | PubMed |
| Stage specific transcriptome profiles at cardiac lineage commitment during cardiomyocyte differentiation from mouse and human pluripotent stem cells. | BMB Rep | 2021 | 34120677 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. | Signal Transduct Target Ther | 2021 | 34108441 | PubTator, text mining | PubMed |
| Genomic insights into body size evolution in Carnivora support Peto's paradox. | BMC Genomics | 2021 | 34107880 | PubTator, text mining | PubMed |
| RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first-second trimester transition. | Biol Open | 2021 | 34100896 | PubTator, text mining | PubMed |
| Crystal structures of aconitase X enzymes from bacteria and archaea provide insights into the molecular evolution of the aconitase superfamily. | Commun Biol | 2021 | 34099860 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy. | Front Oncol | 2021 | 34094963 | PubTator, text mining | PubMed |
| MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells. | J Cancer | 2021 | 34093820 | PubTator, text mining | PubMed |
| MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2. | J Cancer | 2021 | 34093801 | PubTator, text mining | PubMed |
| Autophagy inhibition and microRNA‑199a‑5p upregulation in paclitaxel‑resistant A549/T lung cancer cells. | Oncol Rep | 2021 | 34080652 | PubTator, text mining | PubMed |
| Aneurysm severity is suppressed by deletion of CCN4. | J Cell Commun Signal | 2021 | 34080128 | PubTator, text mining | PubMed |
| Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities. | Cancers (Basel) | 2021 | 34072844 | PubTator, text mining | PubMed |
| Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer-A Comprehensive Review. | Cancers (Basel) | 2021 | 34072842 | PubTator, text mining | PubMed |
| The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation. | Int J Mol Sci | 2021 | 34069715 | PubTator, text mining | PubMed |
| Iron in Translation: From the Beginning to the End. | Microorganisms | 2021 | 34068342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7472/papers?page=53